(Q35262997)

English

Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

8

object named as

G Cormio

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Claes Göran Tropé

6

object named as

C G Tropé

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

7

object named as

A Ayhan

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

author name string

R Y Zang

1

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

P Harter

2

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

D S Chi

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

J Sehouli

4

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

R Jiang

5

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Y Xing

9

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

K M Wollschlaeger

10

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

E I Braicu

11

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

C A Rabbitt

12

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

H Oksefjell

13

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

W J Tian

14

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

C Fotopoulou

15

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

J Pfisterer

16

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

A du Bois

17

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

J S Berek

18

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

language of work or name

0 references

publication date

30 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

105

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

890-896

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

https://scigraph.springernature.com/pub.10.1038/bjc.2011.328

0 references

A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185944

12 July 2018

Multiple imputation in a large-scale complex survey: a practical guide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185944

12 July 2018

Efficacy of pegylated liposomal doxorubicin (PLD) plus carboplatin in ovarian cancer patients who recur within six to twelve months: a phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185944

12 July 2018

Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185944

12 July 2018

Missing data analysis: making it work in the real world

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185944

12 July 2018

Nonplatinum topotecan combinations versus topotecan alone for recurrent ovarian cancer: results of a phase III study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185944

12 July 2018

Use of multiple imputation in the epidemiologic literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185944

12 July 2018

Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwe

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185944

12 July 2018

The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185944

12 July 2018

Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185944

12 July 2018

Radical surgical procedure improves survival time in patients with recurrent ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185944

12 July 2018

Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185944

26 September 2018

Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185944

26 September 2018

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185944

26 September 2018

Optimal Cut-point and Its Corresponding Youden Index to Discriminate Individuals Using Pooled Blood Samples

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.328

21 January 2018

Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21878937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/21878937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of secondary cytoreduction in the management of the first relapse in epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21878937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21878937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/21878937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgery in recurrent epithelial ovarian cancer: benefits on Survival for patients with residual disease of 0.1-1 cm after secondary cytoreduction

1 reference

https://pubmed.ncbi.nlm.nih.gov/21878937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21878937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21878937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival of patients following secondary cytoreductive surgery in ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21878937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary cytoreductive surgery for recurrent epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21878937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary cytoreduction for ovarian cancer following cisplatin therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21878937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21878937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.2011.328

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

release_tdvedzlalzhybhgnzyk6xoseum

1 reference

https://api.fatcat.wiki/v0/release/tdvedzlalzhybhgnzyk6xoseum

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35262997&oldid=1971268515"